Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Gains from Sales and Divestitures (2013 - 2015)

Grifols' (GIFLF) quarterly Gains from Sales and Divestitures came in at $4.8 million in Q3 2015, up 90.26% on a YoY basis from $2.5 million in Q3 2014, and up 526.42% quarter-over-quarter from $764757.8 in Q2 2015.

Analysis

Grifols (GIFLF) Gains from Sales and Divestitures (2013 - 2015) Analysis & Trends

Grifols (GIFLF) has reported Gains from Sales and Divestitures for 3 consecutive years, with $4.8 million the latest figure, recorded in Q3 2015.

  • For the quarter ending Q3 2015, Gains from Sales and Divestitures rose 90.26% year-over-year to $4.8 million; the trailing twelve-month figure through Sep 2015 stood at $8.7 million (up 263.78% YoY), and the FY2012 full-year result was $16.1 million, down 40.19% from the prior year.
  • Gains from Sales and Divestitures grew to $4.8 million in Q3 2015 per GIFLF's latest filing, from $764757.8 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $4.8 million in Q3 2015 and bottomed at -$2.6 million in Q1 2014.
  • Historically, Gains from Sales and Divestitures has averaged $1.5 million across 3 years, with a median of $1.2 million in 2013.
  • The widest YoY moves for Gains from Sales and Divestitures: up 809.2% in 2014, down 172.57% in 2014.
  • Over 3 years, Gains from Sales and Divestitures stood at $276933.1 in 2013, then soared by 809.2% to $2.5 million in 2014, then jumped by 90.26% to $4.8 million in 2015.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $4.8 million, $764757.8, and $581863.7 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 4.79 Mn
Jun 30, 2015 764,757.76
Mar 31, 2015 581,863.73
Sep 30, 2014 2.52 Mn
Jun 30, 2014 2.19 Mn
Mar 31, 2014 -2.60 Mn
Sep 30, 2013 276,933.07
Jun 30, 2013 1.25 Mn
Mar 31, 2013 3.59 Mn